Search

everythinglearnresearchcommunity

for

Search:↓

Being overweight, having gallbladder removal surgery, and taking cholesterol-lowering drugs are linked to a higher chance of getting vulvar lichen sclerosus.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Ocrelizumab may cause total body hair loss in some patients.

Isoflavones from soy may help manage multiple sclerosis symptoms, but more research is needed.

Dermoscopy can help diagnose tuberous sclerosis by identifying unique skin patterns.

MS treatments can cause significant hair loss, affecting mental health.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

Manganese levels in hair may be linked to multiple sclerosis.

Warming hands improves blood flow in people with systemic sclerosis.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Ocrelizumab may cause delayed hair loss in some patients.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Trichoscopy can help diagnose and assess disease activity in connective tissue diseases by identifying specific hair and scalp signs.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Treatment with vitamin A did not improve the child's skin condition.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

A rare ovarian tumor caused a postmenopausal woman to develop male-like features, which improved after surgery.

Rothmund-Thomson syndrome type 2 can cause chronic, poorly healing wounds.